Published in Biomaterials on January 29, 2008
Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A (2008) 1.96
Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev (2012) 1.57
Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression. Tissue Eng Part B Rev (2010) 1.03
Significance of novel bioinorganic anodic aluminum oxide nanoscaffolds for promoting cellular response. Nanotechnol Sci Appl (2011) 0.81
Clinical translation of controlled protein delivery systems for tissue engineering. Drug Deliv Transl Res (2015) 0.81
The future of carbon dioxide for polymer processing in tissue engineering. Tissue Eng Part B Rev (2013) 0.81
Engineering the matrix microenvironment for cell delivery and engraftment for tissue repair. Curr Opin Biotechnol (2013) 0.79
Engineering clinically relevant volumes of vascularized bone. J Cell Mol Med (2015) 0.79
Effect of nano-hydroxyapatite coating on the osteoinductivity of porous biphasic calcium phosphate ceramics. BMC Musculoskelet Disord (2014) 0.79
In Vivo Assessment of Bone Regeneration in Alginate/Bone ECM Hydrogels with Incorporated Skeletal Stem Cells and Single Growth Factors. PLoS One (2015) 0.78
Engineering a biocompatible scaffold with either micrometre or nanometre scale surface topography for promoting protein adsorption and cellular response. Int J Biomater (2013) 0.77
Hypoxia inducible factor-stabilizing bioactive glasses for directing mesenchymal stem cell behavior. Tissue Eng Part A (2014) 0.76
In vivo ultrasonic detection of polyurea crosslinked silica aerogel implants. PLoS One (2013) 0.75
Induction of Angiogenesis by Matrigel Coating of VEGF-Loaded PEG/PCL-Based Hydrogel Scaffolds for hBMSC Transplantation. Mol Cells (2015) 0.75
Human endothelial and foetal femur-derived stem cell co-cultures modulate osteogenesis and angiogenesis. Stem Cell Res Ther (2016) 0.75
The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater (2007) 6.86
Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. Nat Mater (2011) 3.95
Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction (2010) 1.86
Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum (2005) 1.83
Loss of methylation in CpG sites in the NF-κB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes. Arthritis Rheum (2013) 1.70
Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci U S A (2003) 1.48
DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum (2009) 1.46
Incomplete periacetabular acetabuloplasty. Acta Orthop (2014) 1.46
Delivery of definable number of drug or growth factor loaded poly(DL-lactic acid-co-glycolic acid) microparticles within human embryonic stem cell derived aggregates. J Control Release (2013) 1.45
Osteoprogenitor response to semi-ordered and random nanotopographies. Biomaterials (2006) 1.41
Bone tissue engineering: hope vs hype. Biochem Biophys Res Commun (2002) 1.40
Nanotopographical control of stem cell differentiation. J Tissue Eng (2010) 1.38
Late reduction in congenital dislocation of the hip and the need for secondary surgery: radiologic predictors and confounding variables. J Pediatr Orthop (2010) 1.37
The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials (2009) 1.36
Osteoprogenitor response to defined topographies with nanoscale depths. Biomaterials (2005) 1.31
Characterization and multipotentiality of human fetal femur-derived cells: implications for skeletal tissue regeneration. Stem Cells (2005) 1.23
Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1β (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J Biol Chem (2013) 1.22
Temporal analysis of rat growth plates: cessation of growth with age despite presence of a physis. J Histochem Cytochem (2003) 1.22
The use of nanoscale topography to modulate the dynamics of adhesion formation in primary osteoblasts and ERK/MAPK signalling in STRO-1+ enriched skeletal stem cells. Biomaterials (2009) 1.21
Stochasticity and the molecular mechanisms of induced pluripotency. PLoS One (2008) 1.20
Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng (2004) 1.19
Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies. Tissue Eng (2004) 1.19
A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue. Mol Cell Biochem (2003) 1.18
The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes--implications for osteoarthritis. Biochem Biophys Res Commun (2011) 1.15
Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineering. J Bone Miner Res (2003) 1.14
The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials (2009) 1.12
Controlled release of BMP-2 from a sintered polymer scaffold enhances bone repair in a mouse calvarial defect model. J Tissue Eng Regen Med (2012) 1.12
Tissue engineering: strategies, stem cells and scaffolds. J Anat (2008) 1.12
Managing bone and joint infection in children. Arch Dis Child (2012) 1.11
Tissue engineering strategies for cartilage generation--micromass and three dimensional cultures using human chondrocytes and a continuous cell line. Biochem Biophys Res Commun (2005) 1.11
Fabrication of pillar-like titania nanostructures on titanium and their interactions with human skeletal stem cells. Acta Biomater (2009) 1.10
Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering. Adv Drug Deliv Rev (2007) 1.10
Interactions with nanoscale topography: adhesion quantification and signal transduction in cells of osteogenic and multipotent lineage. J Biomed Mater Res A (2009) 1.09
Controlled differentiation of human bone marrow stromal cells using magnetic nanoparticle technology. Tissue Eng Part A (2010) 1.08
Dynamics of anterior-posterior axis formation in the developing mouse embryo. Nat Commun (2012) 1.08
Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization. Arterioscler Thromb Vasc Biol (2010) 1.07
Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions. J Invest Dermatol (2006) 1.07
Epithelial mechanobiology, skin wound healing, and the stem cell niche. J Mech Behav Biomed Mater (2013) 1.06
Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J Orthop Res (2009) 1.06
Experimental characterization and computational modelling of two-dimensional cell spreading for skeletal regeneration. J R Soc Interface (2007) 1.06
Concise review: bridging the gap: bone regeneration using skeletal stem cell-based strategies - where are we now? Stem Cells (2014) 1.05
Skeletal stem cell physiology on functionally distinct titania nanotopographies. Biomaterials (2011) 1.04
Attachment of stem cells to scaffold particles for intra-cerebral transplantation. Nat Protoc (2009) 1.04
Pleiotrophin/Osteoblast-stimulating factor 1: dissecting its diverse functions in bone formation. J Bone Miner Res (2002) 1.03
Genomic expression of mesenchymal stem cells to altered nanoscale topographies. J R Soc Interface (2008) 1.03
Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. Biochem Biophys Res Commun (2011) 1.03
Mathematical modelling of engineered tissue growth using a multiphase porous flow mixture theory. J Math Biol (2006) 1.02
Computational modelling of cell spreading and tissue regeneration in porous scaffolds. Biomaterials (2006) 1.01
Development of specific collagen scaffolds to support the osteogenic and chondrogenic differentiation of human bone marrow stromal cells. Biomaterials (2008) 1.01
Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun (2002) 0.99
Bridging the regeneration gap: stem cells, biomaterials and clinical translation in bone tissue engineering. Arch Biochem Biophys (2008) 0.99
Delivery systems for bone growth factors - the new players in skeletal regeneration. J Pharm Pharmacol (2004) 0.99
Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using "bead-in-bead" polysaccharide capsules. Biomaterials (2007) 0.99
MagicWand: a single, designed peptide that assembles to stable, ordered alpha-helical fibers. Biochemistry (2008) 0.98
Using nanotopography and metabolomics to identify biochemical effectors of multipotency. ACS Nano (2012) 0.98
Chemical modification of mammalian cell surfaces. Chem Soc Rev (2003) 0.98
Strategies to promote chondrogenesis and osteogenesis from human bone marrow cells and articular chondrocytes encapsulated in polysaccharide templates. Tissue Eng (2006) 0.98
Directed differentiation of human embryonic stem cells to interrogate the cardiac gene regulatory network. Mol Ther (2011) 0.97
Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles. Biomaterials (2012) 0.96
The effect of delivery via narrow-bore needles on mesenchymal cells. Regen Med (2009) 0.96
Epidemiology of vitamin D deficiency in children presenting to a pediatric orthopaedic service in the UK. J Pediatr Orthop (2011) 0.96
Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng (2004) 0.96
Plasticization and spraying of poly (DL-lactic acid) using supercritical carbon dioxide: control of particle size. J Pharm Sci (2004) 0.96
Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen (2005) 0.95
In vitro assessment of cell penetration into porous hydroxyapatite scaffolds with a central aligned channel. Biomaterials (2004) 0.95
Immunoselection and adenoviral genetic modulation of human osteoprogenitors: in vivo bone formation on PLA scaffold. Biochem Biophys Res Commun (2002) 0.95
Standardized diagnostic criteria for developmental dysplasia of the hip in early infancy. Clin Orthop Relat Res (2011) 0.94
Expansion of human bone marrow stromal cells on poly-(DL-lactide-co-glycolide) (PDL LGA) hollow fibres designed for use in skeletal tissue engineering. Biomaterials (2007) 0.94
Association of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylation. Arthritis Rheumatol (2014) 0.93
Skeletal stem cells: phenotype, biology and environmental niches informing tissue regeneration. Mol Cell Endocrinol (2008) 0.93
Evaluation of human bone marrow stromal cell growth on biodegradable polymer/bioglass composites. Biochem Biophys Res Commun (2006) 0.93
Scaffolds for liver tissue engineering. Expert Rev Med Devices (2006) 0.92
A novel approach for studying the temporal modulation of embryonic skeletal development using organotypic bone cultures and microcomputed tomography. Tissue Eng Part C Methods (2012) 0.92
Genetic regulation of embryological limb development with relation to congenital limb deformity in humans. J Child Orthop (2008) 0.92
A novel technique for the production of electrospun scaffolds with tailored three-dimensional micro-patterns employing additive manufacturing. Biofabrication (2014) 0.91
Whole proteome analysis of osteoprogenitor differentiation induced by disordered nanotopography and mediated by ERK signalling. Biomaterials (2009) 0.91
Osteoprogenitor response to low-adhesion nanotopographies originally fabricated by electron beam lithography. J Mater Sci Mater Med (2007) 0.91
Nanotopographical control of human osteoprogenitor differentiation. Curr Stem Cell Res Ther (2007) 0.91
Supercritical carbon dioxide: putting the fizz into biomaterials. Philos Trans A Math Phys Eng Sci (2006) 0.91
Control of pore size and structure of tissue engineering scaffolds produced by supercritical fluid processing. Eur Cell Mater (2007) 0.91
Reliability of a New Radiographic Classification for Developmental Dysplasia of the Hip. J Pediatr Orthop (2015) 0.91
Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver. J Hepatol (2010) 0.90
The effect of processing variables on morphological and mechanical properties of supercritical CO2 foamed scaffolds for tissue engineering. Acta Biomater (2011) 0.90
The effect of three-dimensional co-culture of hepatocytes and hepatic stellate cells on key hepatocyte functions in vitro. Cells Tissues Organs (2005) 0.90
The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying. J Control Release (2005) 0.90
Acute haematogenous osteomyelitis in children: is there any evidence for how long we should treat? Curr Opin Infect Dis (2008) 0.89
Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass. Bone (2011) 0.89